ISOLUTE® SCX-3 is a strong cation exchange sorbent used to extract basic analytes from aqueous samples.
ISOLUTE® SCX-3 is a ethylbenzenesulfonic acid bonded sorbent used for the extraction of basic compounds from aqueous (or partially aqueous) samples using a strong cation exchange retention mechanism. It keeps a permanent negative charge across the pH range. Analytes are eluted from ISOLUTE SCX-3 by eliminating the charge on the analyte (high pH), so this sorbent is not suitable for extraction of strong bases. The sorbent is supplied in the protonated form.
ISOLUTE SCX-3 is the sorbent of choice when strong cation exchange with significant secondary non-polar interactions are required.
ISOLUTE SCX-3 is available in a wide range of SPE columns and 96-well plate formats.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
533-0100-B | ISOLUTE® SCX-3 1 g/3 mL | 50 | 323 USD | Add to quote/cart |
533-0100-C | ISOLUTE® SCX-3 1 g/6 mL | 30 | 214 USD | Add to quote/cart |
533-0010-A | ISOLUTE® SCX-3 100 mg/1 mL | 100 | 254 USD | Add to quote/cart |
533-0010-B | ISOLUTE® SCX-3 100 mg/3 mL | 50 | 144 USD | Add to quote/cart |
533-0200-CG | ISOLUTE® SCX-3 2 g/6 mL (Tabless) | 30 | 332 USD | Add to quote/cart |
533-0020-B | ISOLUTE® SCX-3 200 mg/3 mL | 50 | 167 USD | Add to quote/cart |
533-0002-A | ISOLUTE® SCX-3 25 mg/1 mL | 100 | 246 USD | Add to quote/cart |
533-0400-T | ISOLUTE® SCX-3 400 mg/2 mL Array Wells | 100 | 376 USD | Add to quote/cart |
533-0005-A | ISOLUTE® SCX-3 50 mg/1 mL | 100 | 246 USD | Add to quote/cart |
533-0050-B | ISOLUTE® SCX-3 500 mg/3 mL | 50 | 214 USD | Add to quote/cart |
533-0050-C | ISOLUTE® SCX-3 500 mg/6 mL | 30 | 144 USD | Add to quote/cart |
533-0100-P01 | ISOLUTE®-96 SCX-3 100 mg Fixed Well Plate | 1 | 344 USD | Add to quote/cart |
533-0025-P01 | ISOLUTE®-96 SCX-3 25 mg Fixed Well Plate | 1 | 330 USD | Add to quote/cart |
533-0050-P01 | ISOLUTE®-96 SCX-3 50 mg Fixed Well Plate | 1 | 336 USD | Add to quote/cart |
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage